Search results for “Troglitazone” companies
Free sign up to view the full data
Key Players
Order by:
Innovation Intensity
With the analysis among 364 patents, we discovered top 60 key players by total patent application. Bristol Myers Squibb Co., Sankyo Co., Ltd., AstraZeneca Pharmaceutical Co., Ltd. are dominant in this area. They take 44.23% of the total patent filing.
Bristol Myers Squibb Co.
New York, United States
Patent: 84
Sankyo Co., Ltd.
Tokyo-to, Japan
Patent: 52
AstraZeneca Pharmaceutical Co., Ltd.
Jiangsu Sheng, China
Patent: 25
Sandoz AG
Switzerland
Patent: 17
Dr. Reddys Research Foundation
India
Patent: 17
Aeropharm Technology LLC
New Jersey, United States
Patent: 11
Warner-Lambert Co.
New Jersey, United States
Patent: 10
Novartis AG
Basel-Stadt, Switzerland
Patent: 8
Mindset Biopharmaceuticals Usa, Inc.
New York, United States
Patent: 8
Takeda Pharmaceutical Co., Ltd.
Osaka-fu, Japan
Patent: 7
Startups & Unicorns
Order by:
Innovation Intensity
With the analysis among 4 patents, we discovered top 1 start-ups by total patent application.
STARTUP
Institut National de la Santé et de la Recherche Médicale
France
Patent: 4
Fast-Growing
Order by:
Innovation in recent 5 years
With the analysis among related 7 patents applied in the last 5 years. We discover 6 most active companies in this area. The fast-growing Hunan Bojun Biopharmaceutical Co., Ltd., The Schepens Eye Research Institute, Inc., Shenzhen Third People's Hospital take 42.86% of patent filing during this period.
Hunan Bojun Biopharmaceutical Co., Ltd.
Hunan Sheng, China
Patent: 1
The Schepens Eye Research Institute, Inc.
Massachusetts, United States
Patent: 1
Shenzhen Third People's Hospital
undefined undefined
Patent: 1
Soochow University
Jiangsu Sheng, China
Patent: 1
Jinshan Hospital Affiliated to Fudan University (Shanghai Jinshan District Nuclear Chemical Injury Emergency Treatment Center, Shanghai Jinshan District Eye Disease Prevention and Treatment Institute)
undefined undefined
Patent: 1
Zhi Ze Tong Kang (Guangzhou) Biotechnology Co., Ltd.
Guangdong Sheng, China
Patent: 1
New Entrants
Order by:
Innovation in recent 5 years
With the analysis among related 7 patents in last 5 years, we discover 5 new entrants. Hunan Bojun Biopharmaceutical Co., Ltd., Shenzhen Third People's Hospital, Soochow University are the most active new entrants in this area.
Hunan Bojun Biopharmaceutical Co., Ltd.
Hunan Sheng, China
Patent: 1
Shenzhen Third People's Hospital
undefined undefined
Patent: 1
Soochow University
Jiangsu Sheng, China
Patent: 1
Jinshan Hospital Affiliated to Fudan University (Shanghai Jinshan District Nuclear Chemical Injury Emergency Treatment Center, Shanghai Jinshan District Eye Disease Prevention and Treatment Institute)
undefined undefined
Patent: 1
Zhi Ze Tong Kang (Guangzhou) Biotechnology Co., Ltd.
Guangdong Sheng, China
Patent: 1
Research Institutions
Order by:
Innovation Intensity
With the analysis among 46 patents, we discovered top 7 universities and scientific research institutions by total patent application. Korea Advanced Institute of Science & Technology, University of California, Tohoku University are dominant in this area. They take 65.22% of the total patent filing.
Korea Advanced Institute of Science & Technology
South Korea
Patent: 2
University of California
California, United States
Patent: 1
Tohoku University
Miyagi-ken, Japan
Patent: 1
Sichuan University
Sichuan Sheng, China
Patent: 1
President & Fellows of Harvard College
Massachusetts, United States
Patent: 1
Shanghai Institute of Materia Medica Chinese Academy of Sciences
Shanghai Shi, China
Patent: 1
Soochow University
Jiangsu Sheng, China
Patent: 1
Keywords Quick Entry
Popular
Physics
Chemistry
Engineering
Materials science
Computer science
Biology
Medicine
MetalElectrodeVoltageSemiconductorPolymerElectricityCoatingFiberDisplay deviceRaw materialElectric motorUltimate tensile strengthNozzleCarbonBuilding constructionAlkylService lifeElectronOxideOxygenSolventControl unitFlangeControl systemDrugLight sourcePistonDiseaseElectric powerHigh pressure
View more
Page generation time: